Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
active_not_recruiting133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

NCT02394769
terminatedphase_2

Aspirin for Venous Ulcers: Randomised Trial (AVURT)

NCT02333123
unknownphase_4

Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

NCT02022527

Clinical Trials (3)

Showing 3 of 3 trials
NCT02394769Not Applicable

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Active Not Recruiting
NCT02333123Phase 2

Aspirin for Venous Ulcers: Randomised Trial (AVURT)

Terminated
NCT02022527Phase 4

Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3